AI Article Synopsis

  • Dual antiplatelet therapy helps prevent serious blood clot events in patients with conditions like deep vein thrombosis and after stent placements, but it carries a significant risk of bleeding.
  • One of the most serious risks of this therapy is gastrointestinal bleeding, which accounts for nearly half of major bleeding incidents related to its use.
  • A case is presented involving a 74-year-old woman who experienced lower gastrointestinal bleeding after undergoing dual antiplatelet therapy, and she was successfully treated with an endovascular coil procedure.

Article Abstract

Dual antiplatelet therapy is commonly used to treat or prevent thromboembolic events in patients with deep vein thrombosis, pulmonary embolism, atrial fibrillation, in patients after coronary artery stenting, cerebral artery stenting or artificial heart valves, etc. Although they significantly reduce the morbidity and mortality from thromboembolic events, dual antiplatelet therapy is associated with the risk of bleeding, which can be life-threatening. Gastrointestinal bleeding is one of the most common and dangerous events when using dual antiplatelet therapy for a long time. According to studies, nearly half of the major bleeding cases related to dual antiplatelet therapy arise from the gastrointestinal (GI) tract. We report the case of a 74-year-old female patient with lower gastrointestinal bleeding after using dual antiplatelet therapy that was successfully treated endovascularly with a coil.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11456794PMC
http://dx.doi.org/10.1016/j.radcr.2024.08.131DOI Listing

Publication Analysis

Top Keywords

dual antiplatelet
24
antiplatelet therapy
24
gastrointestinal bleeding
12
bleeding dual
8
thromboembolic events
8
artery stenting
8
events dual
8
dual
6
antiplatelet
6
therapy
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!